Official opening of the Biotechnological Hub of the National Institute of Biology and the Zei Awards
On 2nd of February 2024 the National Institute of Biology (NIB) officially opened the new Biotechnological Hub (BTS-NIB). BTS-NIB is an extremely important research infrastructure hub that represents a major milestone in…Read more
“If we don’t speak up, they will not hear!” We were very honoured and grateful to present our CutCancer Project and our research done at NIB (National Institute of Biology), at Research…Read more
Tumours are complex mixture of a heterogeneous population of cells that possess distinct genetic, morphological, and phenotypic profiles, which can affect tumour development and therapeutic resistance. The success of cancer treatments relies…Read more
Dr. Van Maldegem from VUmc is one of the pioneers in using and developing Imaging Mass Cytometry (IMC) method for cancer research. IMC enables detailed and contextual characterisation of protein expression and is…Read more
Discover More About the Project
The overarching aim of CutCancer is to improve the scientific excellence and innovation capacity in the field of 3D in vitro cancer research at the National Institute of Biology, Slovenia.